TY - JOUR
T1 - Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor
T2 - Evidence for the allosteric modulation of the dopamine receptor
AU - Mann, Amandeep
AU - Verma, Vaneeta
AU - Basu, Dipannita
AU - Skoblenick, Kevin J.
AU - Beyaert, Michael G.R.
AU - Fisher, Abigail
AU - Thomas, Nancy
AU - Johnson, Rodney L.
AU - Mishra, Ram K.
N1 - Funding Information:
This work was supported by the National Institutes of Health [Grant NS20036].
PY - 2010/9
Y1 - 2010/9
N2 - The present study was undertaken to investigate the mechanistic role of l-prolyl-l-leucyl-glycinamide (PLG) in modulating agonist binding to the dopamine D2L receptor. Competition and displacement assays indicate that the photoaffinity-labeling peptidomimetics of PLG, 3(R)-[(4(S)-(4-azido-2-hydroxy-benzoyl) amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1a) and 3(R)-[(4(S)-(4-azido-2-hydroxy-5-iodo-benzoyl)amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1b) bind at the same site as PLG. Autoradiography was used to establish the covalent binding of [125I]-1b to a~51kDa protein in bovine striatal membranes. Western blot analysis with a dopamine D2L-specific antibody, in combination with autoradiography, following a two-dimensional gel separation, suggested this~51kDa protein to be the dopamine D2L receptor. Further evidence for binding of 1b to dopamine D2L was provided by samples immunoprecipitated with the D2L antibody. These samples were analyzed by western blotting in parallel with autoradiography of [125I]-1b labeled protein. Both methods revealed bands at~51kDa. Furthermore, PLG is shown to compete with 1b for binding to the dopamine D2L receptor as determined by autoradiography, as well as competition experiments with PLG and 1a. Collectively, these findings suggest the successful development of a photoaffinity-labeling agent, compound 1b, that has been used to elucidate the interaction of PLG specifically with the dopamine D2L receptor.
AB - The present study was undertaken to investigate the mechanistic role of l-prolyl-l-leucyl-glycinamide (PLG) in modulating agonist binding to the dopamine D2L receptor. Competition and displacement assays indicate that the photoaffinity-labeling peptidomimetics of PLG, 3(R)-[(4(S)-(4-azido-2-hydroxy-benzoyl) amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1a) and 3(R)-[(4(S)-(4-azido-2-hydroxy-5-iodo-benzoyl)amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1b) bind at the same site as PLG. Autoradiography was used to establish the covalent binding of [125I]-1b to a~51kDa protein in bovine striatal membranes. Western blot analysis with a dopamine D2L-specific antibody, in combination with autoradiography, following a two-dimensional gel separation, suggested this~51kDa protein to be the dopamine D2L receptor. Further evidence for binding of 1b to dopamine D2L was provided by samples immunoprecipitated with the D2L antibody. These samples were analyzed by western blotting in parallel with autoradiography of [125I]-1b labeled protein. Both methods revealed bands at~51kDa. Furthermore, PLG is shown to compete with 1b for binding to the dopamine D2L receptor as determined by autoradiography, as well as competition experiments with PLG and 1a. Collectively, these findings suggest the successful development of a photoaffinity-labeling agent, compound 1b, that has been used to elucidate the interaction of PLG specifically with the dopamine D2L receptor.
KW - Allosteric
KW - Autoradiography
KW - Dopamine D receptor
KW - L-Prolyl-l-leucyl-glycinamide (PLG)
KW - Melanocyte-stimulating hormone (MSH) inhibiting factor-1 (MIF-1)
KW - Peptidomimetic
UR - http://www.scopus.com/inward/record.url?scp=77954087505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954087505&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2010.05.018
DO - 10.1016/j.ejphar.2010.05.018
M3 - Article
C2 - 20639138
AN - SCOPUS:77954087505
SN - 0014-2999
VL - 641
SP - 96
EP - 101
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2-3
ER -